Cardiol Therapeutics INC

Tejara Capital Limited, through its managed fund Trefoil Select Funds SPC-Stylus SP, has reported beneficial ownership of 6,382,551 Class A Common Shares, representing 5.3% of the outstanding shares in Cardiol Therapeutics Inc.

MMCAP International Inc. SPC and MM Asset Management Inc. jointly reported a 14.9% beneficial ownership stake in Cardiol Therapeutics Inc.'s Class A Common Shares.

Tejara Capital Ltd and Trefoil Select Funds SPC-Stylus SP reported a 5.2% beneficial ownership in Cardiol Therapeutics Inc.'s Class A Common Shares.